TRIP13 and hepatocellular carcinoma: These data revealed an as‐yet unknown and critical role of Trip13 in the regulation of the insulin/Akt signaling pathway and downstream lipid metabolism in HCC cells, suggesting that Trip13‐KD‐dependent Akt activation during interphase was required for the mitotic defects observed in HCC cells.